Five Below Q2 Sales Surge 23% as Retailer Raises Full-Year Guidance
Five Below exceeded Q2 expectations with 23% sales growth and a 14% jump in comparable store sales, driven by successful trend-based merchandising…
Five Below exceeded Q2 expectations with 23% sales growth and a 14% jump in comparable store sales, driven by successful trend-based merchandising…
Matrix Service Company achieves fiscal 2026 profitability, leveraging a new strategic framework to secure major energy and data center infrastructure projects across…
Tilly's posts a return to profitability with $8.4 million in net income, fueled by 12.1% comparable sales growth and disciplined inventory management…
NetApp posted record Q1 results, beating guidance across all metrics as AI-driven data infrastructure demand and strong cloud adoption fueled a 30%…
Phreesia posted a 10% revenue increase to $129.5 million in fiscal Q2 2027, maintaining full-year guidance and achieving its fifth straight quarter…
PVH reports Q2 2026 earnings in line with revenue guidance, bolstered by improved gross margins, effective inventory control, and strong direct-to-consumer momentum…
AGCO CEO Eric Hansotia outlines the company's strategy for managing rising input costs and sector-wide economic pressures impacting global agriculture equipment demand.
Oracle shares face significant volatility as traders anticipate an 11% move following Thursday's earnings report, with analysts weighing strong growth projections against…
Robinhood stock rallies on strong Q2 earnings and expansion into prediction markets, drawing renewed institutional confidence from ARK Investment Management.
Microsoft's record margins face pressure as aggressive Azure infrastructure spending and shifting sales mixes weigh on profitability, signaling potential valuation contraction despite…
Investors are reassessing AI valuations as Broadcom and Credo retreat despite earnings beats, while Snowflake gains momentum on robust cloud consumption metrics.
UnitedHealth's premium valuation of 25.6x earnings faces scrutiny as commercial margin recovery stalls and revenue growth lags behind Cigna and CVS.